Cathepsins B and L were purified from human kidney. SDS/polyacrylamide-gel electrophoresis demonstrated that cathepsins B and L, Mr 27000-30000, consist of disulphide-linked dimers, subunit Mr values 22000-25000 and 5000-7000. The pH optimum for the hydrolysis of methylcoumarylamide (-NHMec) substrates (see below) is approx. 6.0 for each enzyme. Km and kcat are 252 /LM and 364 s-' and 2.2,UM and 25.8 s-1 for the hydrolysis of Z-Phe-Arg-NHMec (where Z-represents benzyloxycarbonyl-) by cathepsins B and L respectively, and 184 gM and 158 s-1 for the hydrolysis of Z-Arg-Arg-NHMec by cathepsin B. A 10 min preincubation of cathepsin B (40°C) or cathepsin L (30°C) with E-64 (2.5 /tM) results in complete inhibition. Under identical conditions Z-Phe-Phe-CHN2 (0.56 ,UM) completely inhibits cathepsin L but has little effect on cathepsin B. Incubation of glomerular basement membrane (GBM) with purified human kidney cathepsin L resulted in dose-dependent (10-40 nM) GBM degradation. In contrast, little degradation of GBM (< 4.0 %o) was observed with cathepsin B. The pH optimum for GBM degradation by cathepsin L was 3.5. Cathepsin L was significantly more active in degrading GBM than was pancreatic elastase, trypsin or bacterial collagenase. These data suggest that cathepsin L may participate in the lysosomal degradation of GBM associated with normal GBM turnover in vivo.
INTRODUCTION
The glomerular basement membrane (GBM), composed primarily of type IV collagen, laminin, fibronectin and proteoglycan, is the primary ultrafiltration barrier of the kidney restricting the passage of plasma proteins into the urine. Isotopic labelling studies (Cohen & Surma, 1980 have indicated a more rapid turnover of both the collagenous and non-collagenous components of the GBM than previously thought (Price & Spiro, 1977) . However, little information is available concerning the enzymes involved in the biosynthesis or degradation of GBM. We have previously reported (O'Connor et al., 1986 ) that normal glomeruli contain relatively high activities of cathepsins B and L, cysteine proteinases with the ability to degrade a variety of protein substrates in vitro (Kirschke et al., 1980 (Kirschke et al., , 1982 & Kirschke, 1981; Mason et al., 1986) . Davies et al. (1978) have reported that human liver cathepsin B causes the release of hydroxyproline from isolated GBM. However, virtually no information is available concerning renal cathepsins B and L, their ability to degrade intact GBM, or their potential role in GBM turnover. In the present study, we have purified and characterized human kidney cathepsins B and L and examined the ability of the purified enzymes to degrade intact GBM. EXPERIMENTAL 
Materials
Bacterial collagenase (type IV), pancreatic elastase (type IV), trypsin (type XI), L-3-carboxy-trans-2,3-epoxypropionyl-leucylamido-(4-guanidino)butane (E-64) and dithiothreitol were from Sigma Chemical Co., St. Louis, MO, U.S.A. Z-Phe-Arg-NHMec and Z-ArgArg-NHMec were from Cambridge Research Biochemicals, Cambridge, U.K. Z-Phe-Phe-CHN2 was a gift from Dr. Elliot Shaw, Friedrich-Miescher-Institut, Basel, Switzerland.
Purification of cathepsins B and L
Human kidneys were obtained at post-mortem and stored at -20 'C. Cathepsin B was purified by affinity chromatography using the semicarbazone of Gly-Pheglycinal linked to Sepharose 4B as previously described (Rich et al., 1986) . Cathepsin L was purified essentially as previously described (Mason et al., 1985) .
Fluorimetric assay for cathepsin B and L
The activities of cathepsins B and L were measured as previously described (Barrett & Kirschke, 1981) with the fluorogenic substrates Z-Phe-Arg-NHMec (cathepsins B and L) and Z-Arg-Arg-NHMec (cathepsin B).
Determination of K. and kcat for cathepsins B and L By use of the assays described above, Km and kcat for the hydrolysis of each peptide methylcoumarylamide substrate were determined by the method of Eisenthal & Cornish-Bowden (1974) . The concentrations of purified cathepsins B and L were determined by active-site titration as previously described (Barrett & Kirschke, 1981 ) with E-64 as the active-site titrant.
GBM isolation
GBM was isolated from bovine kidneys by the method of Blau & Michael (1971) as described in detail in a previous paper (Shah et al., 1987) . GBM prepared by this method is essentially free from interstitial and denatured collagen as determined by SDS/polyacrylamide-gel electrophoresis, lack of digestion by thrombin and electron microscopy (Shah et al., 1987) . GBM degradation GBM degradation was measured as the release of nonsedimentable hydroxyproline during incubation of GBM with purified enzyme as follows. GBM (approx. 12 ,tg of hydroxyproline) was incubated with the enzyme indicated in 400 ,ul (final volume) of buffer (see below). Incubations were carried out for 24 h at 32 + 2°C in a Dubnoff shaking water bath and terminated by centrifuging each tube at 10000 g for 10 min. Hydroxyproline was then determined in each supernatant and pellet after hydrolysis with 6 M-HCI. Results are expressed as the mean+S.E.M. percentage hydroxyproline release [100x (hydroxyproline in supernatant)/(hydroxyproline in supernatant + hydroxyproline in pellet)] for triplicate determinations. Unless specified otherwise, the following buffers, each containing 1 mM-EDTA and 1 mM-dithiothreitol (freshly added), were used: 100 mM-sodium acetate, pH 5.0, for cathepsin L; 100 mM-sodium phosphate, pH 6.0, for cathepsin B. In experiments comparing GBM degradation by various proteinases (Table  2 ) the following buffers were used: 100 mM-Tris/HCl, pH 8.0, containing 0.36 mM-CaCl2 for bacterial collagenase; 100 mM-Tris/HCl, pH 8.8, for pancreatic elastase; 100 mM-Tris/HCI, pH 8.0, for trypsin. Concentrations of these enzymes were estimated on the basis of Mr and 1000 active enzyme.
Other methods
Hydroxyproline was determined by the method of Woessner (1961) as described in detail in a previous paper (Shah et al., 1987) .
SDS/polyacrylamide-gel electrophoresis was performed as previously described (Mason et al., 1985 (Barrett & Kirschke, 1981; Mason et al., 1985) and indicate that there are no major differences in physical or biochemical properties between the enzymes in human kidney and those in other mammalian tissues.
Role of kidney cathepsins B and L in GBM degradation
Incubation of GBM (12 ug of hydroxyproline) with purified cathepsin L (16 pmol) resulted in significant GBM degradation: 59.7 + 4.8 % hydroxyproline released (mean + S.E.M., n = 6). In contrast, only small amounts of hydroxyproline (3.3 + 1.4 %, n = 5) were released during incubation of GBM with cathepsin B, even when relatively large amounts of cathepsin B (187 pmol) were used. GBM degradation by cathepsin L increased with increasing cathepsin L concentrations in the range 10-40 nm (Fig. 1) . The pH optimum for GBM degradation by cathepsin L was 3.5. However, significant GBM degradation, about 50 % of maximum, occurred in the pH range 4.0-5.5 (Fig. 2) , the pH range of the lysosomal vacuole in vivo (Reijngoud & Tager, 1977) . No GBM degradation by cathepsin L was observed at pH 6.0 or higher, possibly owing to the instability of cathepsin L at neutral pH (Mason et al., 1985) . In order to gain some insight into the relative potency of cathepsin L in GBM degradation, we simultaneously examined GBM degradation by cathepsin L and several wellcharacterized proteinases. As shown in Table 2 , cathepsin L was significantly more active in degrading GBM than was pancreatic elastase, trypsin or bacterial collagenase.
It is currently thought that GBM degradation in vivo occurs in at least two steps: an initial extracellular step catalysed by a neutral proteinase(s) that generates phagocytosable GBM fragments, followed by phagocytosis of these fragments and subsequent degradation within the lysosomes. Our results establish that human kidney cathepsin L is a potent GBM-degrading pro- Fig. 2 . Effect of pH on GBM degradation of purified human kidney cathepsin L GBM (approx. 12,ug of hydroxyproline) was incubated with purified cathepsin L for 24 h at 32 + 2°C in the following buffers, each containing 1 mM-EDTA and 1 mmdithiothreitol (added fresh): pH 3.0-4.0, 100 mM-sodium citrate; pH 4.0-5.5, 100 mM-sodium acetate; pH 5.5-6.5, 100 mM-sodium phosphate. Results were calculated as percentage hydroxyproline release for two separate determinations carried out in triplicate and expressed as percentages of maximal activity. Further details are given in the Experimental section.
teinase. The ability of purified cathepsin L to degrade GBM combined with the high activity of cathepsin L in glomeruli suggests that this enzyme may participate in However, the ability of viable cells to release active forms of cathepsin L (Mason et al., 1987) , coupled with their ability to acidify at least small amounts of their extracellular microenvironment (Schenk, 1974; Dingle, 1975; Etherington, 1980) , raises the possibility that cathepsin L could also participate in extracellular GBM degradation associated with either normal GBM turnover or pathological states such as glomerulonephritis.
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